Azmi Nabulsi, M.D., M.P.H.

Azmi Nabulsi, M.D., M.P.H.

Former Chief Operating OfficeratPhathom Pharmaceuticals· In proxies 2022–2025

Pay in FY2025+73% from the year before · Phathom Pharmaceuticals stock +104.3% the same year

Azmi Nabulsi, M.D., M.P.H. was paid $2.7M in FY2025 (Dec), up 73%. Phathom Pharmaceuticals stock rose 104.3% that year.

Pay$100 in the stock at the end of FY21 → $84
Pay is from the Summary Compensation Table of each Phathom Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Phathom PharmaceuticalsPublic company · 4 yr
    • Former Chief Operating Officer2022 – Present · 4 yrStock in role -69%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?